8-K

Company

Nautilus Biotechnology, Inc.

Filed

June 10, 2021

Period of Report

June 9, 2021

Accession Number

0001628280-21-011892

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →